Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026)

Treace Medical Concepts has reported Share-based Compensation for 7 years, with the latest figure at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 7.58% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $33.2 million (up 4.0% YoY), and the FY2025 full-year result was $33.8 million, up 10.52% from the prior year.
• Share-based Compensation for Q1 2026 stood at $8.0 million, up from $7.6 million in the prior quarter.
• The five-year high for Share-based Compensation was $9.6 million in Q2 2025, with the low at $1.4 million in Q1 2022.
• Historically, Share-based Compensation has averaged $5.8 million across 5 years, with a median of $6.7 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 250.5% — and 2025, when it decreased 11.69%.
• Treace Medical Concepts' Share-based Compensation stood at $2.5 million in 2022, then jumped by 137.73% to $5.9 million in 2023, then jumped by 45.69% to $8.6 million in 2024, then declined by 11.69% to $7.6 million in 2025, then rose by 6.34% to $8.0 million in 2026.
• The last three Share-based Compensation figures came in at $8.0 million (Q1 2026), $7.6 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.